Acute telogen effluvium in 503 female patients: The value of the | 3881
Journal of Clinical & Experimental Dermatology Research

Journal of Clinical & Experimental Dermatology Research
Open Access

ISSN: 2155-9554

Acute telogen effluvium in 503 female patients: The value of the effluvium triggering cause to predict female androgenetic alopecia association

4th International Conference and Expo on Cosmetology & Trichology

June 22-24, 2015 Philadelphia, USA

Nicolas Perez-Mora

ScientificTracks Abstracts-Workshop: J Clin Exp Dermatol Res

Abstract :

Acute telogen effluvium (ATE) is often associated with Female Androgenetic Alopecia (FAA) but predictive factors of ATE - FAA association, and clinical factors or therapies which may influence the progression of ATE to Chronic Telogen Effluvium (CTE) have not been reported yet. We have retrospectively analyzed 503 ATE patients with a minimum 1-year follow-up. Demographic and clinical variables considered were: age, year when ATE diagnosis was made, region where patient was located, different oral treatment modalities, and minoxidil topical therapy. Triggering causes were classified as follows: (1) Seasonal hair loss, (2) Severe Diet, (3) Postpartum, (4) Iron deficiency, (5) Psychoemotional stress, (6) Thyroid dysfunction, (7) Medication intake or withdrawal, (8) Antineoplastic therapies and/or major surgery, (9) More than one of the above mentioned. Chronic telogen effluvium (CTE) diagnosis was established when ATE lasted longer than 1 year. FAA diagnosis was always established by the patient�??s physician. Univariate analysis and a binary logistic regression model were used to identify independent predictive factors of ATE�??FAA association and CTE progression. Then, we have identified predictive factors of ATE�??FAA association. Conclusions: Triggering cause is an independent predictive factor of ATE-FFA association. Triggering causes with higher risk of concurrent FAA are: severe diet, iron deficiency and thyroid dysfunction. Patients suffering ATE may benefit from different therapeutic approaches (depending on which is the triggering cause) to prevent or treat their association with FAA. Minoxidil use shows a trend to lower the percentage of progression to CTE.

Biography :

Nicolas Perez-Mora completed his MD, and PhD Degree from Madrid, Spain. He was trained in Clinical Research at Baylor University Medical Center, Dallas, Texas, and at Northwestern Memorial Hospital, Chicago, Illinois during the 90`s. He is first author, or co-author, of 40 PubMed registered publications. He worked as Senior Spain Manager for UpToDate A worldwide trusted evidence-based medicine resource for physician-decisions support. He currently works as Medical & Scientific Advisor for Svenson Medical a hair-care private corporation owning over 60 hair-care centers in Spain, Germany, Switzerland and Portugal. He recently received the Best Clinical Poster Award of the World Congress for Hair Research 2014 in Jeju, Korea.